Protein Expression of Fas, Fas Ligand, Bcl-2 and TGF 2 and Correlation with Survival in Initial and Recurrent Human Gliomas

Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors

1998 • 3,603 citations

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

1991 • 2,815 citations

Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family

1993 • 2,546 citations

The WHO Classification of Tumors of the Nervous System

2002 • 1,931 citations

The proto-oncogene Bcl-2 and its role in regulating apoptosis

1997 • 1,768 citations

Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas Molecule

1994 • 1,120 citations

Fas ligand mediates activation-induced cell death in human T lymphocytes.

1995 • 949 citations

The TGF-β family of growth and differentiation factors

1987 • 675 citations

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

1997 • 403 citations

Apoptosis and therapy

1999 • 294 citations

Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.

1995 • 258 citations

Effects of Colchicine and Radiation on Growth of Normal Tissues and Tumors

1940 • 184 citations

Fas Ligand Expression in Glioblastoma Cell Lines and Primary Astrocytic Brain Tumors

1997 • 153 citations

Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin.

1997 • 145 citations

Glioma Immunology and Immunotherapy

2000 • 141 citations

BCL-2 Family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy

1999 • 127 citations

Expression level of Bcl-2 determines anti- or proapoptotic function.

1999 • 109 citations

Expression of Fas/APO-1 during the progression of astrocytomas.

1995 • 96 citations

Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases

1999 • 87 citations

bcl-2 protein expression in tumors of the central nervous system

1994 • 76 citations

Apoptosis of T lymphocytes invading glioblastomas multiforme: a possible tumor defense mechanism

2002 • 72 citations

Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines

1998 • 60 citations

Bcl-2 expression in higher-grade human glioma: a clinical and experimental study.

2000 • 57 citations

Growth Factors in Gliomas Revisited

2000 • 56 citations

p53, mdm2, EGFR, and msh2 expression in paired initial and recurrent glioblastoma multiforme

2003 • 52 citations

Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study

1996 • 48 citations

bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status

1997 • 47 citations

Expression of bcl-2 in reactive and neoplastic astrocytes: lack of correlation with presence or degree of malignancy

1995 • 47 citations

Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors

1997 • 35 citations

Expression of bcl-2, bax and bcl-xl in human gliomas: a re-appraisal.

2001 • 34 citations

Age-related Expression of p53, Mdm2, EGFR and Msh2 in Glioblastoma Multiforme

2003 • 29 citations

Human astrocytomas co-expressing Fas and Fas ligand also produce TGFbeta2 and Bcl-2.

1999 • 27 citations

Prognostic factors in astrocytomas: relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival.

1997 • 27 citations

Co-expression of Fas and Fas ligand in human non-astrocytic glial tumors

1999 • 17 citations

The expression of apoptosis-related proteins and the apoptotic rate in glial tumors of the brain.

2000 • 12 citations

Soluble CD95 (Fas/APO-1) in malignant glioma: (no) implications for CD95-based immunotherapy?

1998 • 10 citations

Apoptosis and survival in high-grade astrocytomas as related to tumor Fas (APO-1/CD95) expression.

2002 • 9 citations

Expression of Bcl-2 and Bax in oligodendrogliomas and their relationship to apoptosis

1999 • 5 citations